- Home
- KNSA vs EVCM Comparison
KNSA vs EVCM Comparison
Compare KNSA & EVCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNSA
- EVCM
- Stock Information
- Founded
- KNSA 2015
- EVCM 2006
- Country
- KNSA United Kingdom
- EVCM United States
- Employees
- KNSA N/A
- EVCM N/A
- Industry
- KNSA Biotechnology: Pharmaceutical Preparations
- EVCM EDP Services
- Sector
- KNSA Health Care
- EVCM Technology
- Exchange
- KNSA Nasdaq
- EVCM Nasdaq
- Market Cap
- KNSA 2.6B
- EVCM 2.2B
- IPO Year
- KNSA 2018
- EVCM 2021
- Fundamental
- Price
- KNSA $35.92
- EVCM $12.15
- Analyst Decision
- KNSA Strong Buy
- EVCM Buy
- Analyst Count
- KNSA 6
- EVCM 9
- Target Price
- KNSA $40.83
- EVCM $11.89
- AVG Volume (30 Days)
- KNSA 392.6K
- EVCM 215.5K
- Earning Date
- KNSA 10-28-2025
- EVCM 11-11-2025
- Dividend Yield
- KNSA N/A
- EVCM N/A
- EPS Growth
- KNSA N/A
- EVCM N/A
- EPS
- KNSA 0.07
- EVCM N/A
- Revenue
- KNSA $529,332,000.00
- EVCM $710,678,000.00
- Revenue This Year
- KNSA $37.21
- EVCM N/A
- Revenue Next Year
- KNSA $11.99
- EVCM $5.95
- P/E Ratio
- KNSA $542.28
- EVCM N/A
- Revenue Growth
- KNSA 56.18
- EVCM 14.15
- 52 Week Low
- KNSA $17.82
- EVCM $8.10
- 52 Week High
- KNSA $37.34
- EVCM $12.34
- Technical
- Relative Strength Index (RSI)
- KNSA 60.14
- EVCM 63.86
- Support Level
- KNSA $35.29
- EVCM $11.59
- Resistance Level
- KNSA $37.34
- EVCM $11.75
- Average True Range (ATR)
- KNSA 1.00
- EVCM 0.34
- MACD
- KNSA -0.15
- EVCM 0.04
- Stochastic Oscillator
- KNSA 65.30
- EVCM 95.95
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.
About EVCM EverCommerce Inc.
EverCommerce Inc provides tailored Software-as-a-Service solutions for service-based small- and medium-sized businesses (SMBs) in-home services, health services, and fitness & wellness. With a platform serving approximately 708,000 customers across three core verticals, including numerous micro-verticals, their solutions address diverse needs within these sectors. Revenue is mostly generated from the United States. Operating in a single segment, their vertically-tailored SaaS offerings cater to SMBs' specialized demands, enabling them to automate processes, generate business, and enhance customer loyalty. The majority of customers contribute modest revenue, with a small percentage contributing higher amounts.